These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7095602)

  • 41. Effect of changes in prostaglandin synthesis by platelets and vessel wall on the formation of arterial thrombosis in rabbits.
    Kobayashi N; Takada M; Andou K; Maekawa T
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():521-2. PubMed ID: 2936159
    [No Abstract]   [Full Text] [Related]  

  • 42. Contribution of a platelet component to endothelial prostacyclin production despite inhibition of platelet cyclooxygenase activity.
    Czervionke RL; Hoak JC; Haycraft DL; Fry GL; Mann KG
    Trans Assoc Am Physicians; 1982; 95():272-9. PubMed ID: 6820742
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thromboxane A2/prostaglandin H2 mobilizes calcium in human blood platelets.
    Brace LD; Venton DL; Le Breton GC
    Am J Physiol; 1985 Jul; 249(1 Pt 2):H1-7. PubMed ID: 3925795
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of prostaglandins in platelet aggregation in metabolic syndrome].
    Sokolov EI; Lavrenova NIu; Goloborodova IV
    Vestn Ross Akad Med Nauk; 2010; (4):22-6. PubMed ID: 20540350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. (5Z)-carbacyclin displays agonist-antagonist properties on prostacyclin-receptors in platelets and vascular myocytes.
    Corsini A; Oliva D; Folco GC; Giovanazzi S; Noe' MA; Fumagalli R; Nicosia S
    Biomed Biochim Acta; 1988; 47(10-11):S104-7. PubMed ID: 3073757
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Metabolic significance of cyclic nucleotides in the environment for fetal growth--effects of PGI2-like substance on fetal platelet function].
    Kihira M; Matsumoto T; Morikawa F; Ito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 May; 35(5):691-8. PubMed ID: 6306121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Platelet survival and thrombosis.
    Winocour PD; Cattaneo M; Somers D; Richardson M; Kinlough-Rathbone RL; Mustard JF
    Arteriosclerosis; 1982; 2(6):458-66. PubMed ID: 7181734
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endothelial injury and platelet thrombosis in mesenteric arteries of rats: a scanning electron microscopy study.
    Maes L; Andries R; Bourgain RH
    Blood Vessels; 1986; 23(1):1-8. PubMed ID: 3708162
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A method for the study of platelet "white body" formation in the mesenteric arteries of the living animal.
    Van der Byl KV; Honour AJ; Leary WP
    Life Sci; 1982 Dec; 31(26):2985-9. PubMed ID: 7162361
    [No Abstract]   [Full Text] [Related]  

  • 51. Arterial thrombosis and the vessel wall.
    Sixma JJ
    J R Coll Physicians Lond; 1976 Jan; 10(2):202-4. PubMed ID: 1246022
    [No Abstract]   [Full Text] [Related]  

  • 52. [Arterial thrombosis: interaction between the arterial wall, the platelets and the plasma proteins].
    Bourgain RH; Potvliege P; Derwael E; Six F
    Acta Clin Belg; 1975; 30(3):159-66. PubMed ID: 1231453
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug treatment of changes in platelet-vessel wall interactions in burned rats.
    Baluda VP; Lukhoyanova TI; Kozelskaya LV; Zyablitsky VM; Iashvili BP; Vakulenko AD; Staroselskaya AN
    Burns Incl Therm Inj; 1986 Feb; 12(3):176-83. PubMed ID: 3708413
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Concentrations of prostaglandin endoperoxide synthase and prostaglandin I2 synthase in the endothelium and smooth muscle of bovine aorta.
    DeWitt DL; Day JS; Sonnenburg WK; Smith WL
    J Clin Invest; 1983 Dec; 72(6):1882-8. PubMed ID: 6417165
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cyclooxygenase inhibition on platelet-vessel wall interaction.
    Bourgain RH; Andries R; Maes L
    Haemostasis; 1983; 13(2):102-8. PubMed ID: 6409710
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of PGI2 (prostacyclin) synthesis in the arterial wall enhances the formation of white platelet thrombi in vivo.
    Bourgain RH
    Haemostasis; 1978; 7(4):252-5. PubMed ID: 95991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The action of cyclooxygenase and prostacyclin-synthetase inhibitors on platelet-vessel wall interaction.
    Bourgain RH; Six F; Andries R
    Artery; 1980; 8(1):96-100. PubMed ID: 6775620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prostaglandins and thromboxanes: "middlemen" modulating platelet function in hemostasis and thrombosis.
    Gerrard JM; White JG
    Prog Hemost Thromb; 1978; 4():87-125. PubMed ID: 213813
    [No Abstract]   [Full Text] [Related]  

  • 59. Role of prostaglandin biochemical pathway in platelet-vessel wall interaction and local thrombosis.
    Bourgain RH; Andries R; Six F
    Haemostasis; 1982; 11(3):133-8. PubMed ID: 7095602
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.